News and Events


Helsinn Advanced Synthesis wins across all categories 2017 CMO Leadership Awards

March 23rd, 2017

Consistent strong performance sees Helsinn Advanced Synthesis SA win six awards for the third consecutive year in Quality, Reliability, Capabilities, ...

Read article

Helsinn Advanced Synthesis announces investment - Helsinn Advanced Synthesis ann...

February 21st, 2017

Significant new investment totaling CHF15m,supported by Canton of Ticino, prompted by expanding demand for anticancer therapeutics Importanti nuovi in...

Read article

Helsinn Provides Grant for ESMO’s Preceptorship Course on Supportive and Palliat...

February 15th, 2017

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care, announces that the Group has provided a grant to the European Society f...

Read article

Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreem...

February 14th, 2017

Anti-emetic products covered under expanded agreements include ALOXI® and AKYNZEO®. Both are prophylactic agents for the treatment of chemotherapy ind...

Read article

Helsinn Group Launches “Helsinn Cares” Patient Support Services

February 13th, 2017

HelsinnCares Stacked TM RGB 40

Patient Assistance Program and Voucher Program will support both insured and uninsured patients in the United States get access to medicines that can ...

Read article


ESMO 2017 in Madrid

Helsinn will be present in Madrid, Spain on 8-12 September 2017, at the ESMO 2017 congress.

You can meet us at booth #65.

  • 8th September 2017
Full event info

Helsinn will attend at ASCO 2017

The "2017 ASCO Annual Meeting -Making a Difference in Cancer Care" will take place in Chicago, Illinois, on June 2-6 2017

  • 2nd June 2017
Full event info

CPhI Japan-2017

CPhI Japan is the largest japanese pharmaceutical exhibition

  • 19th April 2017
Full event info